Hypoxic volume evaluated by 18F-fluoromisonidazole positron emission tomography (FMISO-PET) may be a prognostic factor in patients with oral squamous cell carcinoma: preliminary analyses.

MLA

Sato, J., et al. “Hypoxic Volume Evaluated by 18F-Fluoromisonidazole Positron Emission Tomography (FMISO-PET) May Be a Prognostic Factor in Patients with Oral Squamous Cell Carcinoma: Preliminary Analyses.” International Journal of Oral & Maxillofacial Surgery, vol. 47, no. 5, May 2018, pp. 553–60. EBSCOhost, https://doi.org/10.1016/j.ijom.2017.09.007.

APA

Sato, J., Kitagawa, Y., Watanabe, S., Asaka, T., Ohga, N., Hirata, K., Shiga, T., Satoh, A., & Tamaki, N. (2018). Hypoxic volume evaluated by 18F-fluoromisonidazole positron emission tomography (FMISO-PET) may be a prognostic factor in patients with oral squamous cell carcinoma: preliminary analyses. International Journal of Oral & Maxillofacial Surgery, 47(5), 553–560. https://doi.org/10.1016/j.ijom.2017.09.007

Chicago

Sato, J., Y. Kitagawa, S. Watanabe, T. Asaka, N. Ohga, K. Hirata, T. Shiga, A. Satoh, and N. Tamaki. 2018. “Hypoxic Volume Evaluated by 18F-Fluoromisonidazole Positron Emission Tomography (FMISO-PET) May Be a Prognostic Factor in Patients with Oral Squamous Cell Carcinoma: Preliminary Analyses.” International Journal of Oral & Maxillofacial Surgery 47 (5): 553–60. doi:10.1016/j.ijom.2017.09.007.